Chemomab Therapeutics
Latest round
- Series B
Last raised
- Dec 2017
Total raised
- $15M
Investors
- 3
About Chemomab Therapeutics
Established in 2011 and based in Tel Aviv, Israel, Chemomab Therapeutics Ltd. operates as a biopharmaceutical company that develops monoclonal antibodies for the treatment of immune-mediated and fibrotic disorders. In July 2024, Chemomab Therapeutics Ltd. The CM-101 is the firm’s lead clinical candidate, is a monoclonal antibody that targets CCL24. The novel CM-101 proprietary platform hinders the fundamental function of the soluble chemokine CCL24 as a regulator of major inflammatory and fibrotic pathways in multiple fibrosis-related disorders. The product interferes with the underlying biology of fibrosis using a novel and differentiated mechanism of action. The organization is advancing CM-101 into phase 2 studies to treat patients with liver fibrosis (Primary Sclerosing Cholangitis) and patients suffering from skin and lung fibrosis (Systemic Sclerosis).
Who invested in Chemomab Therapeutics
3 investors across 2 rounds
See all investors in Chemomab Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chemomab Therapeutics
Who invested in Chemomab Therapeutics?
Chemomab Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chemomab Therapeutics raised?
Chemomab Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Chemomab Therapeutics last raise money?
Chemomab Therapeutics's most recent round on record is a Series B, in Dec 2017.
What does Chemomab Therapeutics do?
Established in 2011 and based in Tel Aviv, Israel, Chemomab Therapeutics Ltd.
Where is Chemomab Therapeutics headquartered?
Chemomab Therapeutics is headquartered in Tel Aviv, Israel.
Which VCs invest in companies like Chemomab Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Chemomab Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Chemomab Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.